CASI PHARMACEUTICALS, INC. Other than Temporary Impairment Losses, Investments
CASI PHARMACEUTICALS, INC. (CASIF) reported Other than Temporary Impairment Losses, Investments of -$6.38 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2023-04-26
| Period end | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|
| 2022-12-31 | -$6.38M 20-F · filed 2023-04-26 |
| 2021-12-31 | -$1.45M 20-F · filed 2023-04-26 |